JPMorgan Chase & Co. set a €24.00 ($26.97) target price on Evonik Industries (FRA:EVK) in a research report sent to investors on Wednesday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.
Several other research firms have also commented on EVK. Sanford C. Bernstein set a €32.00 ($35.96) target price on shares of Evonik Industries and gave the company a buy rating in a report on Thursday, July 2nd. UBS Group set a €20.00 ($22.47) price target on shares of Evonik Industries and gave the stock a sell rating in a research note on Wednesday. Credit Suisse Group set a €21.50 ($24.16) price objective on Evonik Industries and gave the company a neutral rating in a research report on Thursday, May 7th. Nord/LB set a €20.00 ($22.47) target price on Evonik Industries and gave the company a neutral rating in a research note on Tuesday, May 26th. Finally, HSBC set a €20.00 ($22.47) price target on Evonik Industries and gave the company a neutral rating in a report on Friday, April 3rd. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and nine have given a buy rating to the company’s stock. Evonik Industries has an average rating of Hold and a consensus target price of €24.81 ($27.88).
Evonik Industries stock opened at €23.76 ($26.70) on Wednesday. The firm’s 50 day simple moving average is €23.08 and its 200 day simple moving average is €23.35. Evonik Industries has a 1-year low of €26.78 ($30.09) and a 1-year high of €32.97 ($37.04).
About Evonik Industries
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Featured Story: High-Yield Dividend Stocks
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.